Enliven Therapeutics, Inc.
Enliven Therapeutics, Inc. (ELVN) — Form 8-K: Current report
About this filing
Enliven Therapeutics, Inc. (ELVN) filed an 8-K on Nov 5, 2026 reporting results of operations (earnings) (Item 2.02), with exhibits (Item 9.01).
Key facts
- Item 2.02 · Results of operations (earnings)
- Item 9.01 · Financial statements and exhibits
More ELVN filings
- 10-Q
Filed Nov 5, 2026
- 4
Filed Nov 3, 2026
- SC 13G/A
Filed Oct 27, 2026
- 4
Filed Oct 21, 2026
- 4
Filed Oct 21, 2026
- 144
Filed Oct 19, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.